Michael Handley is the founder of Cytocom. Cytocom has raised $100M in total funding. Latest round: IPO. Based in Fort Collins, United States.
Michael Handley is the CEO and Chairman of Sparta Healthcare Acquisition, a blank check company targeting biotechs with mid-to-late stage therapeutic candidates. Sparta Healthcare Acquisition filed to raise $100 million in an initial public offering in May 2021. He has served as the CEO of Cytocom since 2020 and has assisted in or led the global commercialization of 17 devices or drugs during his career.
Full founder directory · Investor directory · Company funding database · Fundraising library